期刊文献+

单核苷酸多态性与血液学肿瘤的研究进展 被引量:2

Correlation between Single Nucleotide Polymorphisms and Hematological Malignancies——Review
下载PDF
导出
摘要 单核苷酸多态性(single nucleotide polymorphisms,SNP)是第3代分子遗传标志,SNP决定基因的功能单位和人群遗传变异的内在特征。它反映了个体表型、疾病易感性和对药物、环境因子反应的差异。血液肿瘤是一种多基因遗传病,涉及到多个遗传易感基因的作用。本文就近年来单核苷酸多态性与其在血液肿瘤研究领域(致癌物质代谢酶基因的SNP、DNA修复基因的SNP、癌基因与抑癌基因的SNP、药物代谢相关酶基因的SNP等)的相关进展作一综述。 Single nucleotidc polymorphisms (SNPs) are the 3rd generation of molecular genetic markers of humam populations. SNPs determine the functional units of genes and the inherent characteristics of genetic variation, and reflect the individual phenotype, disease susceptibility and differences of response to drug and environmental factors. Hematological malignancy is a multi-gene genetic diseases, and involve in the role of multigenetic susceptible genes. This review intends to introduce the single nucleotide polymorphisms and their relevant progress of research on hematologic malignancies, including the SNP of carcinogen-metabolizing enzymes genes, the SNP of DNA repair genes, the SNP of oncogenes and anti-oncogene genes, the SNP of drug-metabolizing enzyme genes and so on.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第1期250-254,共5页 Journal of Experimental Hematology
基金 863计划(编号2007AA022007)
关键词 单核苷酸多态性 血液肿瘤 遗传标志 single nucleotide polymorphism hematological malignancy genetic marker
  • 相关文献

参考文献29

  • 1赵广荣,扬帆,元英进,髙秀梅,张军平.单核苷酸多态性检测方法的新进展[J].遗传,2005,27(1):123-129. 被引量:19
  • 2方唯意,姚开泰.高通量SNP基因分型技术研究进展[J].国外医学(分子生物学分册),2003,25(6):333-336. 被引量:10
  • 3Gra OA, Glotov AS, Nikitin EA, et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hemato1,2008 ; 83 ( 4 ) :279 - 287.
  • 4Gra OA, Glotov AS, Kozhekbaeva Zh, et al. Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol( Mosk), 2008 ;42(2) :214 - 225.
  • 5Zhang J, Zhu FY, Pu YP, et al. Analysis of multiple single nucleotide polymorphisms (SNPs) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Hart population. J Toxicol Environ Health A,2007 ; 70( 11 ) :901 - 907.
  • 6宋宝,祝敬燕,刘杰,王哲海,石艳,吕丽燕,郑燕.核苷酸剪切修复酶XPD基因多态性与非霍奇金淋巴瘤发病风险的研究[J].中国实验血液学杂志,2008,16(1):97-100. 被引量:8
  • 7Kuptsova N, Kopecky KJ, Godwin J, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood,2007 ; 109 (9) :3936 - 3944.
  • 8Danoy P, Sonoda E, Lathrop M, et al. A naturally occurring genetie variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage. Biochem Biophys Res Commun, 2007 ;352 ( 3 ) :763 - 768.
  • 9Batar B, Gtiven M, Baris S, et al. DNA repair gene XPD and XRCCI polymorphisms and the risk of childhood acute lymphohlastic leukemia. Leuk Res,2009 ; 33 (6) 759 - 763.
  • 10Lahiri O, Harris S, Packham G, et al. p53 pathway gene single nucleotide polymorphisms and chronic lymphocytic leukemia. Cancer Genet Cytogenet,2007 ;179( 1 ) :36 -44.

二级参考文献63

  • 1王苏梅,刘学军,吴爱华.亚甲基四氢叶酸还原酶基因多态性及临床意义[J].国外医学(遗传学分册),2005,28(1):29-32. 被引量:17
  • 2余慧,金润铭,白燕,林雯.急性淋巴细胞白血病患儿亚甲基四氢叶酸还原酶多态性与氨甲蝶呤毒副反应的研究[J].中华儿科杂志,2005,43(4):302-303. 被引量:26
  • 3陈宝安,姜妮,祭美菊,侯鹏,陆祖宏,高冲,丁家华,孙耘玉,王骏,程坚,赵刚.新型亚甲基四氢叶酸还原酶单核苷酸多态性研究方法检测恶性血液病易感性[J].中国实验血液学杂志,2006,14(6):1069-1073. 被引量:3
  • 4黄华 等.第一军医大学学报,2002,22(7):602-602.
  • 5Sherry S T, Ward M H, Kholodov M, Baker J, Phan L, Smigielski E M, Sirotkin K. dbSNP: the NCBI database of genetic variation.Nucleic acids Res, 2001, 29: 308~311.
  • 6Brown P O,Hartwell L.Genomics and human disease--variations on variation.Nat Genet, 1998, 18:91~93.
  • 7Evans W E,Reling M V.Pharmacogenomics: translating functional genomics into rational therapeutics.Science, 1999, 286:487~491.
  • 8Wang D G,Fan J B,Siao C J,Berno A, Young P,Sapolsky R,Ghandour G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L, Topaloglou T, Hubbell E, Robinson E, Mittmann M, Morris M S, Shen N P, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson T J, Lipshutz R, Chee M, Lander E S. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphism in the human genome.Science, 1998, 280: 1077~1082.
  • 9Pastinen T,Ratitio M, Lindroos K,Tainola P,Peltonen L,Syvanen A C.A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays.Genome Res, 2000, 10: 1031~1042.
  • 10Lareu M,Sobrino B,Phillips C,Torres M,Brion M,Carracedo A.Typing Y-chromosome single-nucleotide polymorphisms with DNA microarray technology. Intern Congress Series, 2003, 1239: 21~25.

共引文献64

同被引文献15

  • 1杨朝晖,张锦华,杨学忠,陈世浩,张学,金春莲,姜莉,孙开来.差示聚合酶链式反应检测骨髓转移的神经母细胞瘤N-myc扩增及临床意义[J].中华小儿外科杂志,1996,17(4):195-198. 被引量:2
  • 2Kohl NE, Kanda N, Sohreclc RR, et al. Transposition and amplifica- tion of oncogene related sequences in human neuroblastoma. Cell, 1983,35 (2 Pt 1 ) :359-367.
  • 3Westermark UK, Wilhelm M,Frenzel A,et al. The MYCN Oncogene and Differentiation in Neuroblastoma. Semin Cancer Biol, 2011,21 (4) :256-266.
  • 4Souzaki R, Tajiri T, Teshiba R, et al. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of dip- loid neuroblastomas without MYCN amplification. J Pediatr Surg, 2011,46 ( 12 ) :2228-2232.
  • 5Egler RA, Burlingame SM, Nuchtem JG, et al. lnterleukin-6 and sol- uble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma. Clin Cancer Res, 2008,14 (21) :7028-7034.
  • 6Hatzi E, Murphy C, Zoephel A, et al. N-myc oncogene overexpres- sion down-regulates IL46; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene, 2002, 21 (22) :3552-3561.
  • 7SoharaY, Shimada H, Minkin C, Erdreich-Epstein A, et al. Bone marrow mesenchymal stem cells provide an alternate pathway of os- teoclast activation and bone destruction by cancer cells. Cancer Res, 2005,65 (4) :1129-1135.
  • 8Lagmay JP, London WB, Gross TG, et al. Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblas- toma:rs1800795 (promoter) and rs8192284 (receptor). Clin Cancer Res,2009,15(16) :5234-5239.
  • 9Vahteristo P, Syrjikoski K, Heikkinen T, et al. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition. EurJ Hum Genet, 2006,14 ( 2 ) : 167 -172.
  • 10Capasso M,Devoto M,Hou C,et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet, 2009, 41 (6) :718-723.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部